RT Journal Article
SR Electronic
T1 Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.18.21251504
DO 10.1101/2021.02.18.21251504
A1 Douglas dos-Santos
A1 Ana C. G. Salina
A1 Tamara S. Rodrigues
A1 Marlon F. Rocha
A1 Edismauro G. Freitas-Filho
A1 Daniel L. Alzamora-Terrel
A1 Mikhael H. F. de Lima
A1 Daniele B. C. Nascimento
A1 Ícaro Castro
A1 Camila M. Silva
A1 Juliana E. Toller-Kawahisa
A1 Amanda Becerra
A1 Samuel Oliveira
A1 Diego B. Caetité
A1 Leticia Almeida
A1 Adriene Y. Ishimoto
A1 Thais M. Lima
A1 Ronaldo B. Martins
A1 Flavio Veras
A1 Natália B. do Amaral
A1 Marcela C. Giannini
A1 Letícia P. Bonjorno
A1 Maria I. F. Lopes
A1 Maira N. Benatti
A1 Sabrina S. Batah
A1 Rodrigo C. Santana
A1 Fernando C. Vilar
A1 Maria A. Martins
A1 Rodrigo L. Assad
A1 Sergio C. L. de Almeida
A1 Fabiola R. de Oliveira
A1 Eurico Arruda Neto
A1 Thiago M. Cunha
A1 José C. Alves-Filho
A1 Fernando Q. Cunha
A1 Alexandre T. Fabro
A1 Helder Nakaya
A1 Dario S. Zamboni
A1 Paulo Louzada-Junior
A1 Rene D. R. Oliveira
A1 Larissa D. Cunha
YR 2021
UL http://medrxiv.org/content/early/2021/02/23/2021.02.18.21251504.abstract
AB COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering immunopathogenesis are not established. The functional plasticity of macrophages allows this cell type to promote pathogen elimination and inflammation or suppress inflammation and promote tissue remodeling and injury repair. During an infection, the clearance of dead and dying cells, a process named efferocytosis, can modulate the interplay between these contrasting functions. Here, we show that engulfment of SARS-CoV2-infected apoptotic cells (AC) exacerbates inflammatory cytokine production, inhibits the expression of efferocytic receptors, and impairs continual efferocytosis by macrophages. We also provide evidence that monocytes from severe COVID-19 patients express reduced levels of efferocytic receptors and fail to uptake AC. Our findings reveal that dysfunctional efferocytosis of SARS-CoV-2-infected cell corpses suppress macrophage anti-inflammation and efficient tissue repair programs and provide mechanistic insights for the pathogenesis of the hyperinflammation and extensive tissue damage associated with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the Fundo de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2018/255594 and 2020/052886), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES 88887.507253/202000) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 434538/20183)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The procedures followed in the study were approved by the Research Ethics Committee of Hospital das Clinicas de Ribeirao Preto (CEP-FMRP/USP) and by the National Ethics Committee, Brazil (Comissao Nacional de Etica em Pesquisa (CONEP), protocols 30248420.9.0000.5440 and 39722020.9.0000.5440.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFurther information and requests for data should be directed to and will be fulfillled by the Lead Contact, Larissa D. Cunha